Tafamidis, Pfizer’s treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), has been granted a priority review designation from the FDA, potentially speeding its path to approval.

Adults with congenital heart disease (CHD) report better health-related quality of life (HRQoL) when treated with surgical or catheter interventions rather than drug therapy or surveillance, according to research published Jan. 8 in the American Journal of Cardiology.

One in five patients who required emergency surgery to correct complications caused by diagnostic angiography or percutaneous coronary intervention (PCI) died within 30 days, researchers reported in a single-center study from Germany.

Participating in telemedicine for ischemic stroke care could modestly lower a hospital’s rate of tissue-type plasminogen activator (tPA)-related complications and in-hospital mortality, researchers reported in Circulation: Cardiovascular Quality and Outcomes.

Although childhood cancer survival has improved markedly over the past few decades, a new study out of the Netherlands suggests a greater proportion of those survivors are at risk of developing heart failure at young ages, due in part to cardiotoxic treatments.

Research published in Stroke Jan. 10 suggests clinicians overestimate the severity of intracerebral hemorrhage (ICH) and underestimate the severity of acute ischemic stroke (AIS), resulting in a bias that could influence patients’ outcomes and treatment plans.

Clinicians’ personal beliefs about the safety and efficacy of statins play a larger role in their likelihood of prescribing the medications than their knowledge of cholesterol guidelines, according to a study published Jan. 4 in the American Journal of Cardiology.

Men who are dissatisfied with their marriages are around 86 percent more likely to experience sudden cardiac death (SCD) than those who are very satisfied, according to research published in the Jan. 1 edition of the American Journal of Cardiology.